PI
IBIO icon

PFG Investments’s iBio IBIO Stock Holding History

PFG Investments’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38K Sell
20,000
-1,500
-7% -$3.48K ﹤0.01% 1166
2025
Q4 		$41.5K Buy
+21,500
New +$29.3K ﹤0.01% 1122

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

PFG Investments's IBIO Position: Q1 2026 in Review

PFG Investments reduced its iBio (IBIO) stake by 7% in Q1 2026, selling an estimated $3.48K and leaving 20,000 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

PFG Investments first reported a position in IBIO in Q4 2025 and has held it in 2 quarters since. The position peaked at $41.5K in Q4 2025. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • PFG Investments held 20,000 shares of iBio worth $38K as of Q1 2026.
  • PFG Investments sold 1,500 iBio shares in Q1 2026, an estimated $3.48K.
  • iBio made up ﹤0.01% of PFG Investments's portfolio in Q1 2026, its #1166 holding.
  • PFG Investments first reported a position in iBio in Q4 2025 and has held it in 2 quarters since.
  • PFG Investments's iBio position peaked at $41.5K in Q4 2025.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on PFG Investments's 13F filing for Q1 2026, filed 27 Apr 2026.